Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
about
CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
P2860
Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical characteristics and p ...... ion regulatory gene mutations.
@en
Clinical characteristics and p ...... ion regulatory gene mutations.
@nl
type
label
Clinical characteristics and p ...... ion regulatory gene mutations.
@en
Clinical characteristics and p ...... ion regulatory gene mutations.
@nl
prefLabel
Clinical characteristics and p ...... ion regulatory gene mutations.
@en
Clinical characteristics and p ...... ion regulatory gene mutations.
@nl
P2093
P2860
P1433
P1476
Clinical characteristics and p ...... ion regulatory gene mutations.
@en
P2093
Anna Kobayashi
Atsushi Marumo
Eri Kawata
Fumiko Kosaka
Hayato Tamai
Hiroki Yamaguchi
Ikuko Omori
Kazuki Terada
Kazutaka Nakayama
Keiko Fukunaga
P2860
P304
P356
10.3324/HAEMATOL.2016.143073
P50
P577
2016-05-31T00:00:00Z